DE SB249 | 2017-2018 | 149th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on June 13 2018 - 25% progression, died in committee
Action: 2018-06-13 - Introduced and Assigned to Health, Children & Social Services Committee in Senate
Pending: Senate Health, Children & Social Services Committee
Text: Latest bill text (Draft #1) [HTML]
Status: Introduced on June 13 2018 - 25% progression, died in committee
Action: 2018-06-13 - Introduced and Assigned to Health, Children & Social Services Committee in Senate
Pending: Senate Health, Children & Social Services Committee
Text: Latest bill text (Draft #1) [HTML]
Summary
This Act, modeled on similar laws in Virginia and Maryland, requires a health care provider to provide notice to a patient at the time blood is drawn to perform a laboratory test for Lyme disease that explains the limitations of the test and instructs the patient to see their health care provider if the patient continues to experience unexplained symptoms.
Title
An Act To Amend Title 16 Of The Delaware Code Relating To The Provision Of Information About Lyme Disease.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2018-06-13 | Introduced and Assigned to Health, Children & Social Services Committee in Senate |
